Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		May 04, 2024		Apr. 29, 2023
Income Statement [Abstract]
Net sales		$ 457,597	[1]	$ 483,332	[2]
Cost of sales		241,316		254,524
Gross margin		216,281		228,808
Selling and administrative expenses		247,831		251,497
Asset impairments and other, net	[3]	578		308
Operating loss		(32,128)		(22,997)
Other components of net periodic benefit cost		109		92
Interest expense, net		890		1,651
Loss from continuing operations before income taxes		(33,127)		(24,740)
Income tax benefit		(8,839)		(5,865)
Loss from continuing operations		(24,288)		(18,875)
Loss from discontinued operations, net of tax		(59)		(15)
Net Loss		$ (24,347)		$ (18,890)
Basic loss per common share:
Continuing operations (in dollars per share)		$ (2.22)		$ (1.6)
Discontinued operations (in dollars per share)		(0.01)		0
Net loss (in dollars per share)		(2.23)		(1.6)
Diluted loss per common share:
Continuing operations (in dollars per share)		(2.22)		(1.6)
Discontinued operations (in dollars per share)		(0.01)		0
Net loss (in dollars per share)		$ (2.23)		$ (1.6)
Weighted average shares outstanding:
Basic (in shares)		10,930		11,818
Diluted (in shares)		10,930		11,818

[1] Net sales in North America and in the U.K., which includes the ROI, accounted for 80% and 20%, respectively, of our net sales in the first quarter of Fiscal 2025

[2] Net sales in North America and in the U.K., which includes the ROI, accounted for 81% and 19%, respectively, of our net sales for the first quarter of Fiscal 2024.

[3] Asset impairments and other includes a $0.3 million charge for asset impairments in Journeys Group and $0.3 million for severance.